Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Trading Up 4.3% – Still a Buy?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX)’s stock price shot up 4.3% on Thursday . The company traded as high as $18.43 and last traded at $18.46. 16,741 shares changed hands during trading, a decline of 33% from the average session volume of 25,053 shares. The stock had previously closed at $17.70.

Analyst Upgrades and Downgrades

TLX has been the topic of several research reports. William Blair raised Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a report on Tuesday, November 19th. UBS Group upped their target price on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a “buy” rating in a report on Monday, January 27th.

Telix Pharmaceuticals Limited American Depositary Shares Price Performance

The stock’s 50-day simple moving average is $17.19.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.